• 1. State Key Laboratory of Cardiovascular Disease, Center of Vascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, P.R.China;
  • 2. Department of Vascular Surgery, The Second Xiangya Hospital of Central South University, Changsha, 410008, P.R.China;
  • 3. Department of Vascular Surgery, Fuwai Yunnan Cardiovascular Hospital, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, 650220, P.R.China;
SHU Chang, Email: changshu@vip.126.com
Export PDF Favorites Scan Get Citation

Aortic arch disease is one of the research hotspots and treatment difficulties in the field of aorta, including aortic arch aneurysms, pseudoaneurysm, ulcer, dissection and intramural hematoma. By summarizing the clinical data of the vascular surgery center of Fuwai Hospital of Chinese Academy of Medical Sciences in the past five years and combining with the latest theories of the cutting-edge development of aortic surgery, the authors proposed the "HENDO" concept, including using hybrid technique (H), endovascular repair (Endo) and open surgery (O), properly to treat aortic arch pathologies individually. The authors advocated the establishment of HENDO team and cooperation mechanism in large aortic centers, to eliminate technical shortcomings of a single surgeon by fully mastering the three main technology clusters by teamwork. Accordingly, the best treatment for each patient can be administrated and the survival rate and quality of life can be improved eventually.

Citation: LUO Mingyao, SHU Chang, FANG Kun, YU Cuntao, QIAN Xiangyang, SUN Xiaogang. Aortic arch repair by "HENDO" technology clusters. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2020, 27(9): 987-991. doi: 10.7507/1007-4848.202002088 Copy

  • Previous Article

    Chinese expert consensus on surgical treatment of congenital heart disease (8): Series of procedures for univentricular heart
  • Next Article

    《2020 CCS/CHRS 立场声明:器质性心脏病患者室性心动过速和心室颤动的管理》解读